September 2026
131 articles-

Sep 14 · 20:21World News
McConnell Back in the Senate After Three Months Away
-

Sep 14 · 17:54Market Watch
BlackRock Edges Past Pfizer Into the S&P 500's No. 77 Slot
-

Sep 14 · 16:01Bio Business News
Abbott Settles Formula Plant Shutdown Case for $385 Million
-

Sep 14 · 14:54World News
Kennedy Returns to the Anti-Vaccine Group He Once Led
-

Sep 14 · 13:41Bio Business News
Novo Nordisk Drops the Nordisk as Doustdar Rethinks Obesity
-

Sep 14 · 12:36Bio Business News
GSK Winds Down German Flu Vaccine Plant, 650 Jobs Go
-

Sep 14 · 11:30Bio Business News
Soon-Shiong Leads $11.3 Million First Close at PDS Biotech
-

Sep 14 · 10:00Market Watch
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
-

Sep 14 · 09:58Bio Business News
Sanofi Hands 20 Legacy Medicines to Cheplapharm in Pipeline Reset
-

Sep 14 · 08:51Bio Business News
Alcon Chief Warns MFN Pricing Could Keep Drugs From Europe
-

Sep 13 · 20:25Biotechnology Daily
Diabetes Researchers Halt Grant Reviews in ADA Boycott
-

Sep 13 · 17:51Biotechnology Daily
FDA's New Oncology Chief Pledges to Keep OCE's Reforms Going
-

Sep 13 · 16:07Biotechnology Daily
Cardiovascular Setbacks at Novartis and Novo Nordisk Chill a Hot Field
-

Sep 13 · 14:58Biotechnology Daily
FDA Adds Three Months to Exelixis Colorectal Cancer Review
-

Sep 13 · 13:44Biotechnology Daily
GSK's Hansoh ADC Posts 18.5-Month Survival in Lung Cancer
-

Sep 13 · 12:35Biotechnology Daily
Three Small-Cap Biotechs Face Make-or-Break 2026 Readouts
-

Sep 13 · 11:24Bio Business News
GE HealthCare Weighs $1 Billion Sofie Biosciences Buyout
-

Sep 13 · 09:36Biotechnology Daily
Akeso Spells Out the Survival Data Behind Its Keytruda Beat
-

Sep 13 · 08:53Bio Business News
Sandoz Chief Warns 'Patients Pay the Tariff' on Generics
-

Sep 12 · 20:24Biotechnology Daily
FDA Pushes Back Exelixis Colorectal Decision; Shares Fall 2.28%
-

Sep 12 · 17:54Biotechnology Daily
Rasonque's Approval Opens the RAS Field's Real Race
-

Sep 12 · 16:05World News
Medicaid Frailty 'Tiers' Will Decide Who Skips Work Rules
-

Sep 12 · 14:53Market Watch
ARKG Became the Softer Way to Trade Moderna's Swing
-

Sep 12 · 13:45World News
EU Court Adviser Moves to Void Pharma's 80% Wastewater Levy